NOVO-NORDISK NAM.B DK-,20 [NOVC]
stock DE:NOVC (FRANKFURT)

Alternative ID: DK0060534915 DK0060534915

Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Exchange: FRANKFURT
Sector: Healthcare
Industry: Biotechnology
Market Cap: Mega (278.68B)
Data in EUR

EPS: 2.42
Current PE: 50.80
BVPS: 3.85
Price/BVPS: 0.00
Dividend: 9.10 / 7.6%

Hist Grade: B (78.73)
YOY Grade: C (64.48)
Debt/FCF: 0.51
ROIC: 71.2%
PEG: 6.46
PEGY: 3.30

Value Price: 74.93
MOS Price: 37.47
MOS %:
Graham Number: 14.48
Graham MOS %:
IRT: 0.00

Market Price

0.00

0.00 0.0%

as of Mar 20 '23

52 Week Range:

0.00 126.68

Stock Analyzer Tutorials

General Info

type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

Financial Statements

type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

Growth Grade and Financial Ratios

type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

Price Charts

type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Exchange: FRANKFURT
Sector: Healthcare
Industry: Biotechnology
Market Cap: Mega (278.68B)
Inst. Ownership: 41.65%
Insider Ownership: 0.00%
Full Time Employees: 50816

Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement

Cash Flow Statement

Balance Sheet

Liquidity Ratios

Current Ratio

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Equity (BVPS)	1.64	1.71	1.91	1.92	2.22	2.18	2.52	2.60	2.95	3.41	3.85
growth rate		4.3%	11.7%	0.5%	15.6%	-1.8%	15.6%	3.2%	13.5%	15.6%	12.9%
Earnings BIT	2,947.39	29,474.00	31,493.00	34,492.00	46,619.00	48,432.00	48,967.00	47,248.00	52,483.00	54,476.00	59,341.00
growth rate		900.0%	6.9%	9.5%	35.2%	3.9%	1.1%	-3.5%	11.1%	3.8%	8.9%
Avg.PE	22.32	23.75	21.32	21.77	21.77	17.16	19.42	16.02	16.02	16.02	16.02
growth rate		6.4%	-10.2%	2.1%	0.0%	-21.2%	13.2%	-17.5%	0.0%	0.0%	0.0%
ROA	27.12	32.88	37.03	35.93	41.29	40.06	38.15	36.25	32.96	31.15	28.14
growth rate		21.2%	12.6%	-3.0%	14.9%	-3.0%	-4.8%	-5.0%	-9.1%	-5.5%	-9.7%
ROE	45.95	54.90	60.54	63.92	79.90	82.23	80.20	76.00	71.19	69.70	71.24
growth rate		19.5%	10.3%	5.6%	25.0%	2.9%	-2.5%	-5.2%	-6.3%	-2.1%	2.2%
ROIC	45.02	54.18	60.02	63.09	78.31	81.11	78.65	74.44	66.55	62.14	55.89
growth rate		20.4%	10.8%	5.1%	24.1%	3.6%	-3.0%	-5.4%	-10.6%	-6.6%	-10.1%
Cur. Ratio	1.91	1.86	1.74	1.37	1.35	1.26	1.28	1.09	1.06	0.94	0.86
growth rate		-2.6%	-6.5%	-21.3%	-1.5%	-6.7%	1.6%	-14.8%	-2.8%	-11.3%	-8.5%
Quick Ratio	1.45	1.37	1.22	0.99	1.03	0.95	0.90	0.79	0.76	0.64	0.65
growth rate		-5.5%	-11.0%	-18.9%	4.0%	-7.8%	-5.3%	-12.2%	-3.8%	-15.8%	1.6%
Leverage	1.73	1.62	1.65	1.91	1.95	2.15	2.05	2.14	2.18	2.29	2.75
growth rate		-6.4%	1.9%	15.8%	2.1%	10.3%	-4.7%	4.4%	1.9%	5.1%	20.1%
Balance Sheet	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Acct.Receivable	11,115.00	12,027.00	15,174.00	19,001.00	21,613.00	24,197.00	23,551.00	26,889.00	29,152.00	32,184.00	46,799.00
growth rate		8.2%	26.2%	25.2%	13.8%	12.0%	-2.7%	14.2%	8.4%	10.4%	45.4%
Acct.Payable	3,291.00	3,859.00	4,092.00	4,950.00	4,927.00	6,011.00	5,833.00	6,756.00	6,358.00	5,717.00	8,870.00
growth rate		17.3%	6.0%	21.0%	-0.5%	22.0%	-3.0%	15.8%	-5.9%	-10.1%	55.2%
Cur.Assets	39,591.00	40,163.00	42,058.00	46,293.00	55,140.00	59,766.00	60,080.00	59,067.00	62,456.00	65,809.00	85,595.00
growth rate		1.4%	4.7%	10.1%	19.1%	8.4%	0.5%	-1.7%	5.7%	5.4%	30.1%
Total Assets	64,698.00	65,669.00	70,337.00	77,062.00	91,799.00	97,539.00	102,355.00	110,769.00	125,612.00	144,922.00	194,508.00
growth rate		1.5%	7.1%	9.6%	19.1%	6.3%	4.9%	8.2%	13.4%	15.4%	34.2%
Cash	13,408.00	11,553.00	10,728.00	14,396.00	16,923.00	18,690.00	18,852.00	15,638.00	15,475.00	12,757.00	10,720.00
growth rate		-13.8%	-7.1%	34.2%	17.6%	10.4%	0.9%	-17.1%	-1.0%	-17.6%	-16.0%
Inventory	9,433.00	9,543.00	9,552.00	11,357.00	12,758.00	14,341.00	15,373.00	16,336.00	17,641.00	18,536.00	19,621.00
growth rate		1.2%	0.1%	18.9%	12.3%	12.4%	7.2%	6.3%	8.0%	5.1%	5.9%
Cur.Liabilities	20,779.00	21,638.00	24,225.00	33,689.00	40,873.00	47,436.00	47,056.00	54,164.00	58,983.00	70,273.00	99,516.00
growth rate		4.1%	12.0%	39.1%	21.3%	16.1%	-0.8%	15.1%	8.9%	19.1%	41.6%
Liabilities	27,250.00	25,037.00	27,768.00	36,768.00	44,830.00	52,270.00	52,540.00	58,930.00	68,019.00	81,597.00	123,762.00
growth rate		-8.1%	10.9%	32.4%	21.9%	16.6%	0.5%	12.2%	15.4%	20.0%	51.7%
LT Debt	502.00	0.00	0.00								9,654.00
growth rate		-100.0%
Equity	5,033.01	5,460.94	42,569.00	40,294.00	46,969.00	45,269.00	49,815.00	51,839.00	57,593.00	63,325.00	70,746.00
growth rate		8.5%	679.5%	-5.3%	16.6%	-3.6%	10.0%	4.1%	11.1%	10.0%	11.7%
Common Shares	2,851.00	2,758.00	2,694.00	2,630.00	2,578.00	2,535.00	2,478.00	490.00	480.00	470.00	462.00
growth rate		-3.3%	-2.3%	-2.4%	-2.0%	-1.7%	-2.3%	-80.2%	-2.0%	-2.1%	-1.7%
Cash Flow Statement	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Capital Expenditures	3,073.00	3,372.00	3,238.00	3,990.00	5,224.00	7,068.00	7,626.00	9,636.00	8,932.00	5,825.00	6,335.00
growth rate		9.7%	-4.0%	23.2%	30.9%	35.3%	7.9%	26.4%	-7.3%	-34.8%	8.8%
Cash Dividends	766.08	1,040.52	9,715.00	11,866.00	12,905.00	23,830.00	18,844.00	19,048.00	19,409.00	20,121.00	21,517.00
growth rate		35.8%	833.7%	22.1%	8.8%	84.7%	-20.9%	1.1%	1.9%	3.7%	6.9%
Cash From OA	21,374.00	22,214.00	25,942.00	31,692.00	38,287.00	48,314.00	41,168.00	44,616.00	46,782.00	51,951.00	55,000.00
growth rate		3.9%	16.8%	22.2%	20.8%	26.2%	-14.8%	8.4%	4.9%	11.1%	5.9%
FCF per Share	0.88	1.01	0.90	1.33	1.59	2.04	2.05	1.73	2.06	2.56	2.34
growth rate		14.8%	-10.9%	47.8%	19.6%	28.3%	0.5%	-15.6%	19.1%	24.3%	-8.6%
FCF	18,042.00	18,592.00	22,298.00	27,357.00	31,881.00	40,047.00	32,520.00	32,206.00	35,551.00	29,870.00	47,615.00
growth rate		3.1%	19.9%	22.7%	16.5%	25.6%	-18.8%	-1.0%	10.4%	-16.0%	59.4%
Income Statement	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Sales	66,346.00	78,026.00	83,572.00	88,806.00	107,927.00	111,780.00	111,696.00	111,831.00	122,021.00	126,946.00	140,800.00
growth rate		17.6%	7.1%	6.3%	21.5%	3.6%	-0.1%	0.1%	9.1%	4.0%	10.9%
Op.Income	17,097.00	29,474.00	31,493.00	34,492.00	46,619.00	48,432.00	48,967.00	47,248.00	52,483.00	54,476.00	59,341.00
growth rate		72.4%	6.9%	9.5%	35.2%	3.9%	1.1%	-3.5%	11.1%	3.8%	8.9%
IBT	2,946.72	3,737.80	32,539.00	34,096.00	43,483.00	47,798.00	48,680.00	47,615.00	48,553.00	53,130.00	59,080.00
growth rate		26.9%	770.5%	4.8%	27.5%	9.9%	1.9%	-2.2%	2.0%	9.4%	11.2%
Net Income	17,097.00	21,432.00	25,184.00	26,481.00	34,860.00	37,925.00	38,130.00	38,628.00	38,951.00	42,138.00	47,757.00
growth rate		25.4%	17.5%	5.2%	31.6%	8.8%	0.5%	1.3%	0.8%	8.2%	13.3%
EPS	6.00	7.77	9.35	10.07	13.52	14.96	15.39	15.93	16.38	18.01	20.74
growth rate		29.5%	20.3%	7.7%	34.3%	10.7%	2.9%	3.5%	2.8%	10.0%	15.2%
Gross Profit	53,757.00	64,561.00	69,432.00	74,244.00	91,739.00	94,597.00	94,064.00	94,214.00	101,933.00	106,014.00	117,142.00
growth rate		20.1%	7.5%	6.9%	23.6%	3.1%	-0.6%	0.2%	8.2%	4.0%	10.5%
R&D	1,294.00	1,464.56	11,733.00	13,762.00	13,608.00	14,563.00	14,014.00	14,805.00	14,220.00	15,112.00	17,199.00
growth rate		13.2%	701.1%	17.3%	-1.1%	7.0%	-3.8%	5.6%	-4.0%	6.3%	13.8%

Quarterly Statements

Item Name	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Earnings BIT	14,779.00	15,249.00	14,331.00	19,147.00	18,391.00
growth rate		3.2%	-6.0%	33.6%	-4.0%
Balance Sheet	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Acct.Receivable	30,223.00	35,452.00	46,799.00	44,166.00	46,639.00
growth rate		17.3%	32.0%	-5.6%	5.6%
Acct.Payable	7,616.00	8,877.00	8,870.00	6,679.00	14,654.00
growth rate		16.6%	-0.1%	-24.7%	119.4%
Cur.Assets	77,146.00	91,213.00	85,595.00	86,537.00	102,979.00
growth rate		18.2%	-6.2%	1.1%	19.0%
Total Assets	158,095.00	174,084.00	194,508.00	197,136.00	218,928.00
growth rate		10.1%	11.7%	1.4%	11.1%
Cash	24,229.00	29,493.00	10,720.00	13,394.00	22,758.00
growth rate		21.7%	-63.7%	24.9%	69.9%
Inventory	18,822.00	18,899.00	19,621.00	20,289.00	21,706.00
growth rate		0.4%	3.8%	3.4%	7.0%
Cur.Liabilities	72,798.00	88,328.00	99,516.00	95,602.00	109,655.00
growth rate		21.3%	12.7%	-3.9%	14.7%
Liabilities	92,536.00	107,972.00	123,762.00	130,586.00	144,476.00
growth rate		16.7%	14.6%	5.5%	10.6%
LT Debt			9,654.00	24,084.00	24,178.00
growth rate				149.5%	0.4%
Equity	65,559.00	66,112.00	70,746.00	66,550.00	74,452.00
growth rate		0.8%	7.0%	-5.9%	11.9%
Common Shares	462.00	462.00	462.00	462.00	456.00
growth rate		0.0%	0.0%	0.0%	-1.3%
Cash Flow Statement	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Capital Expenditures	1,709.00	1,175.00	2,049.00	1,520.00	2,435.00
growth rate		-31.3%	74.4%	-25.8%	60.2%
Cash Dividends	1.00	8,021.00	15,690.00	15,690.00
growth rate		802,000.0%	95.6%	0.0%
Cash From OA	25,255.00	21,507.00	-3,017.00	23,586.00	23,961.00
growth rate		-14.8%	-100.0%	100.0%	1.6%
FCF	23,546.00	20,332.00	-5,066.00	22,066.00	21,526.00
growth rate		-13.7%	-100.0%	100.0%	-2.5%
Income Statement	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Sales	33,041.00	35,622.00	38,333.00	42,031.00	41,265.00
growth rate		7.8%	7.6%	9.7%	-1.8%
Op.Income	14,779.00	15,249.00	14,331.00	19,147.00	18,391.00
growth rate		3.2%	-6.0%	33.6%	-4.0%
IBT	14,917.00	15,112.00	13,113.00	17,919.00	16,795.00
growth rate		1.3%	-13.2%	36.7%	-6.3%
Net Income	12,123.00	12,119.00	10,892.00	14,210.00	13,318.00
growth rate		0.0%	-10.1%	30.5%	-6.3%
EPS
growth rate
Gross Profit	27,494.00	29,563.00	32,092.00	35,114.00	35,196.00
growth rate		7.5%	8.6%	9.4%	0.2%
R&D	3,944.00	4,252.00	5,059.00	5,206.00	5,123.00
growth rate		7.8%	19.0%	2.9%	-1.6%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

B (78.73)

YOY Growth Grade:

C (64.48)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Dividend Yield: 7.6%
Beta: 0.31
Beta of 0.3077 suggests that the asset is less volatile than the rest of the market.
PE: 50.80
EY: 2.0%
PEG: 6.46
PEG Ratio of 6.46 suggests that stock is overpriced.
PEGY: 3.30
PEGY Ratio of 3.30 suggests that stock is overpriced.
Price/BVPS: 0.00
Price to BVPS Ratio of 0.00 suggests that stock is undervalued.

Profitability Ratios

ROE: 71.2%
Return on Equity (ROE) of 71.2% suggests that a company is doing well.
ROS: 42.2%
The value of Return on Sales depends on the business and/or industry. Usually the higher ratio the better.
ROA: 30.4%
Return on Assets (ROA). Low ratio usually means poor performance, or ineffective use of assets by management. High ratio usually means good performance.
ROI: 83.5%
Return on Investment (ROI) of 83.5% suggests that a company is doing well.
ROIC: 71.2%
Return on Invested Capital (ROIC) of 71.2% suggests that a company is doing well.

Liquidity Ratios

Current Ratio: 0.86
Current Ratio of 0.86 suggests that a company may not be able to pay off bills as rapidly as it should.
Quick Ratio: 0.58
Quick Ratio of 0.58 suggests that a company does not have enough cash to cover immediate liabilities.
Cash Turnover: -10.11
Turnover Of Cash Ratio of -10.11 suggests that a company may have funds tied up in short-term low-yielding assets or may have a cash surplus, which is not invested in the business.
Equity Ratio: 36.4%
Equity Ratio of 36.4% suggests that a company has high financing and debt service costs, not very attractive to investors.
Debt/Equity: 174.9%
Debt to Equity Ratio of 174.9% suggests that greater risk assumed by creditors, hence greater interest by them in the way the company is being managed.
Debt/FCF: 0.51
Debt/FCF of 0.51 suggests that a company is doing well and can pay off its long term debt within three years.

Efficiency Ratios

Avg Collection Period: 121.32
Average Collection Period of 121.32 days suggests a slow turnover, which may be the result of a number of bad accounts, or a tax collection policy or perhaps credit is being used to generate sales.
Inventory Turnover: 1.21
Inventory Turnover Ratio of 1.21 suggests a large inventory, a never-out-of-stock situation, perhaps some obsolete items, or it could indicate poor liquidity and possible overstocking of items.
Cash Flow Ratio: 7.49
Cash Flow Ratio of 7.49 suggests a company is doing OK, but lower inventory is generally viewed as a positive trend.
Profit Margin: 33.9%

Value Price

PE and EPS

	Historical	Current	Forward
PE	50.80	50.80	25.57
EPS / Growth		2.42

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 13.7%

Estimates	Pessimistic	Moderate	Optimistic
Rate of Return	15.0%
MOS Price %	50 %
Future EPS Growth	13.7%	13.7%	13.7%
Future PE	25.57	34.60	34.60
Future EPS	8.76	8.76	8.76
Value Price MOS %	55.37	74.93	74.93
MOS Price	27.69	37.47	37.47
IRT

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Graham Number: 14.48
Graham MOS:

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.